These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28549745)

  • 1. [Anti-ageing therapies in Alzheimer's disease].
    Alonso Abreu GS; Brito Armas JM; Castro Fuentes R
    Rev Esp Geriatr Gerontol; 2018; 53(1):45-53. PubMed ID: 28549745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Does Alzheimer's disease exist in all primates? Alzheimer pathology in non-human primates and its pathophysiological implications (II)].
    Toledano A; Álvarez MI; López-Rodríguez AB; Toledano-Díaz A; Fernández-Verdecia CI
    Neurologia; 2014; 29(1):42-55. PubMed ID: 21871692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuronal amyloid-β accumulation within cholinergic basal forebrain in ageing and Alzheimer's disease.
    Baker-Nigh A; Vahedi S; Davis EG; Weintraub S; Bigio EH; Klein WL; Geula C
    Brain; 2015 Jun; 138(Pt 6):1722-37. PubMed ID: 25732182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic mouse models of brain ageing and Alzheimer's disease.
    Bilkei-Gorzo A
    Pharmacol Ther; 2014 May; 142(2):244-57. PubMed ID: 24362083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Epidemiology of Alzheimer's Disease Modifiable Risk Factors and Prevention.
    Zhang XX; Tian Y; Wang ZT; Ma YH; Tan L; Yu JT
    J Prev Alzheimers Dis; 2021; 8(3):313-321. PubMed ID: 34101789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Feeding and nutrition in Alzheimer's disease].
    Ferrero López MI; Botella Trelis JJ
    Nutr Hosp; 2000; 15(6):280-90. PubMed ID: 11216096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Alzheimer's disease: New therapeutic strategies].
    Villegas S
    Med Clin (Barc); 2015 Jul; 145(2):76-83. PubMed ID: 25245784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of early diagnosis and its impact on the management and course of Alzheimer's disease.
    Chang CY; Silverman DH
    Expert Rev Mol Diagn; 2004 Jan; 4(1):63-9. PubMed ID: 14711350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage.
    Vos SJ; Verhey F; Frölich L; Kornhuber J; Wiltfang J; Maier W; Peters O; Rüther E; Nobili F; Morbelli S; Frisoni GB; Drzezga A; Didic M; van Berckel BN; Simmons A; Soininen H; Kłoszewska I; Mecocci P; Tsolaki M; Vellas B; Lovestone S; Muscio C; Herukka SK; Salmon E; Bastin C; Wallin A; Nordlund A; de Mendonça A; Silva D; Santana I; Lemos R; Engelborghs S; Van der Mussele S; ; Freund-Levi Y; Wallin ÅK; Hampel H; van der Flier W; Scheltens P; Visser PJ
    Brain; 2015 May; 138(Pt 5):1327-38. PubMed ID: 25693589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Creativity and dementia: emerging diagnostic and treatment methods for Alzheimer's disease.
    Cummings JL; Miller BL; Christensen DD; Cherry D
    CNS Spectr; 2008 Feb; 13(2 Suppl 2):1-20; quiz 22. PubMed ID: 18264030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid beta peptide immunotherapy in Alzheimer disease.
    Delrieu J; Ousset PJ; Voisin T; Vellas B
    Rev Neurol (Paris); 2014 Dec; 170(12):739-48. PubMed ID: 25459121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New and emerging treatments for Alzheimer's disease.
    Corbett A; Smith J; Ballard C
    Expert Rev Neurother; 2012 May; 12(5):535-43. PubMed ID: 22550982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterizing Alzheimer's disease through metabolomics and investigating anti-Alzheimer's disease effects of natural products.
    Yi L; Liu W; Wang Z; Ren D; Peng W
    Ann N Y Acad Sci; 2017 Jun; 1398(1):130-141. PubMed ID: 28632966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and management of Alzheimer's disease: past, present and future ethical issues.
    Gauthier S; Leuzy A; Racine E; Rosa-Neto P
    Prog Neurobiol; 2013 Nov; 110():102-13. PubMed ID: 23578568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and management of Alzheimer's disease--an update.
    Srinivas P
    Med J Malaysia; 1999 Dec; 54(4):541-9; quiz 550. PubMed ID: 11072482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's disease prevention: A way forward.
    Bermejo-Pareja F; Llamas-Velasco S; Villarejo-Galende A
    Rev Clin Esp (Barc); 2016 Dec; 216(9):495-503. PubMed ID: 27325510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Future directions in Alzheimer's disease from risk factors to prevention.
    Imtiaz B; Tolppanen AM; Kivipelto M; Soininen H
    Biochem Pharmacol; 2014 Apr; 88(4):661-70. PubMed ID: 24418410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive enhancement therapy for Alzheimer's disease. The way forward.
    Parnetti L; Senin U; Mecocci P
    Drugs; 1997 May; 53(5):752-68. PubMed ID: 9129864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding Epigenetic Alterations in Alzheimer's and Parkinson's Disease: Towards Targeted Biomarkers and Therapies.
    Ciceri F; Rotllant D; Maes T
    Curr Pharm Des; 2017; 23(5):839-857. PubMed ID: 28120717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. beta-Amyloid as a molecular therapeutic target in Alzheimer's disease.
    Adlard PA; James SA; Bush AI; Masters CL
    Drugs Today (Barc); 2009 Apr; 45(4):293-304. PubMed ID: 19499094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.